Healthcare Contacts Regarding Circulatory Conditions among Swedish Patients in Opioid Substitution Treatment, with and without On-Site Primary Healthcare
Abstract
:1. Introduction
2. Materials and Methods
2.1. Setting
2.2. Participants
2.3. Procedures
2.3.1. Registrations for Circulatory Problems
2.3.2. Healthcare Utilization for Circulatory Problems
2.3.3. On-Site PHC Utilization
2.4. Analysis
3. Results
3.1. Sample Characteristics
3.2. Healthcare Contacts Regarding Circulatory Conditions
3.3. Correlates of On-Site PHC
4. Discussion
5. Conclusions
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Acknowledgments
Conflicts of Interest
References
- Degenhardt, L.; Bucello, C.; Mathers, B.; Briegleb, C.; Ali, H.; Hickman, M.; McLaren, J. Mortality among regular or dependent users of heroin and other opioids: A systematic review and meta-analysis of cohort studies. Addiction 2011, 106, 32–51. [Google Scholar] [CrossRef]
- Federman, A.D.; Arnsten, J.H. Primary care affiliations of adults in a methadone program with onsite care. J. Addict. Dis. 2007, 26, 27–34. [Google Scholar] [CrossRef]
- Mattick, R.P.; Breen, C.; Kimber, J.; Davoli, M. Methadone maintenance therapy versus no opioid replacement therapy for opioid dependence. Cochrane Database Syst. Rev. 2009, 2009, CD002209. [Google Scholar] [CrossRef] [PubMed]
- Mattick, R.P.; Breen, C.; Kimber, J.; Davoli, M. Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence. Cochrane Database Syst. Rev. 2014, 2014, CD002207. [Google Scholar] [CrossRef]
- Gao, L.; Robertson, J.R.; Bird, S.M. Non drug-related and opioid-specific causes of 3262 deaths in Scotland’s methadone-prescription clients, 2009–2015. Drug Alcohol Depend. 2019, 197, 262–270. [Google Scholar] [CrossRef] [PubMed]
- Von Greiff, N.; Skogens, L.; Berlin, M.; Bergmark, A. Mortality and Cause of Death-A 30-Year Follow-Up of Substance Misusers in Sweden. Subst. Use Misuse 2018, 53, 2043–2051. [Google Scholar] [CrossRef] [Green Version]
- WHO. Global Health Estimates 2016: Deaths by Cause, Age, Sex, by Country and by Region, 2000–2016. Geneva. 2018. Available online: https://www.who.int/healthinfo/global.../GHE2016_Deaths_WBInc_2000_2016.xls (accessed on 11 February 2019).
- Reece, A.S.; Hulse, G.K. Lifetime opiate exposure as an independent and interactive cardiovascular risk factor in males: A cross-sectional clinical study. Vasc Health Risk Manag. 2013, 9, 551–561. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Sadeghian, S.; Darvish, S.; Davoodi, G.; Salarifar, M.; Mahmoodian, M.; Fallah, N.; Karimi, A.A. The association of opium with coronary artery disease. Eur. J. Cardiovasc. Prev. Rehabil. 2007, 14, 715–717. [Google Scholar] [CrossRef] [PubMed]
- Isbister, G.K.; Brown, A.L.; Gill, A.; Scott, A.J.; Calver, L.; Dunlop, A.J. QT interval prolongation in opioid agonist treatment: Analysis of continuous 12-lead electrocardiogram recordings. Br. J. Clin. Pharmacol. 2017, 83, 2274–2282. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Fareed, A.; Patil, D.; Scheinberg, K.; Blackinton Gale, R.; Vayalapalli, S.; Casarella, J.; Drexler, K. Comparison of QTc interval prolongation for patients in methadone versus buprenorphine maintenance treatment: A 5-year follow-up. J. Addict. Dis. 2013, 32, 244–251. [Google Scholar] [CrossRef]
- Colville, T.; Sharma, V.; Albouaini, K. Infective endocarditis in intravenous drug users: A review article. Postgrad. Med. J. 2016, 92, 105–111. [Google Scholar] [CrossRef] [PubMed]
- Robertson, R.; Broers, B.; Harris, M. Injecting drug use, the skin and vasculature. Addiction 2020. [Google Scholar] [CrossRef]
- Islam, M.M.; Taylor, A.; Smyth, C.; Day, C.A. General health of opioid substitution therapy clients. Intern Med. J. 2013, 43, 1335–1338. [Google Scholar] [CrossRef]
- Han, B.; Polydorou, S.; Ferris, R.; Blaum, C.S.; Ross, S.; McNeely, J. Demographic Trends of Adults in New York City Opioid Treatment Programs--An Aging Population. Subst. Use Misuse 2015, 50, 1660–1667. [Google Scholar] [CrossRef] [PubMed]
- Vallecillo, G.; Robles, M.J.; Torrens, M.; Samos, P.; Roquer, A.; Martires, P.K.; Sanvisens, A.; Muga, R.; Pedro-Botet, J. Metabolic syndrome among individuals with heroin use disorders on methadone therapy: Prevalence, characteristics, and related factors. Subst. Abus. 2018, 39, 46–51. [Google Scholar] [CrossRef] [PubMed]
- Zirakzadeh, A.; Schuman, C.; Stauter, E.; Hays, J.T.; Ebbert, J.O. Cigarette smoking in methadone maintained patients: An up-to-date review. Curr. Drug Abuse Rev. 2013, 6, 77–84. [Google Scholar] [CrossRef] [PubMed]
- Troberg, K.; Håkansson, A.; Dahlman, D. Self-Rated Physical Health and Unmet Healthcare Needs among Swedish Patients in Opioid Substitution Treatment. J. Addict. 2019, 2019, 7942145. [Google Scholar] [CrossRef] [Green Version]
- Richter, K.P.; Gibson, C.A.; Ahluwalia, J.S.; Schmelzle, K.H. Tobacco use and quit attempts among methadone maintenance clients. Am. J. Public Health 2001, 91, 296–299. [Google Scholar] [CrossRef] [Green Version]
- Mehta, S.; Parmar, N.; Kelleher, M.; Jolley, C.J.; White, P.; Durbaba, S.; Ashworth, M. COPD and asthma in patients with opioid dependency: A cross-sectional study in primary care. NPJ Prim. Care Respir. Med. 2020, 30, 4. [Google Scholar] [CrossRef] [Green Version]
- Cotton, B.P.; Bryson, W.C.; Bruce, M.L. Methadone Maintenance Treatment for Older Adults: Cost and Logistical Considerations. Psychiatr. Serv. 2018, 69, 338–340. [Google Scholar] [CrossRef] [PubMed]
- Rosen, D.; Smith, M.L.; Reynolds, C.F. , 3rd. The prevalence of mental and physical health disorders among older methadone patients. Am. J. Geriatr. Psychiatry 2008, 16, 488–497. [Google Scholar] [CrossRef]
- Pierce, M.; Millar, T.; Robertson, J.R.; Bird, S.M. Ageing opioid users’ increased risk of methadone-specific death in the UK. Int. J. Drug Policy 2018, 55, 121–127. [Google Scholar] [CrossRef]
- McCoy, C.B.; Metsch, L.R.; Chitwood, D.D.; Miles, C. Drug use and barriers to use of health care services. Subst. Use Misuse 2001, 36, 789–806. [Google Scholar] [CrossRef] [PubMed]
- Chitwood, D.D.; Comerford, M.; McCoy, H.V. Satisfaction with access to health care among injection drug users, other drug users, and nonusers. J. Behav. Health Serv. Res. 2002, 29, 189–197. [Google Scholar] [CrossRef]
- Powelson, E.; Lorvick, J.; Lutnick, A.; Wenger, L.; Klausner, J.; Kral, A.H. Unmet healthcare need among women who use methamphetamine in San Francisco. Subst. Use Misuse 2014, 49, 243–252. [Google Scholar] [CrossRef] [PubMed]
- Miller-Lloyd, L.; Landry, J.; Macmadu, A.; Allard, I.; Waxman, M. Barriers to Healthcare for People Who Inject Drugs: A Survey at a Syringe Exchange Program. Subst. Use Misuse 2020, 55, 896–899. [Google Scholar] [CrossRef]
- Öhlin, L.; Fridell, M.; Nyhlén, A. Buprenorphine maintenance program with contracted work/education and low tolerance for non-prescribed drug use: A cohort study of outcome for women and men after seven years. BMC Psychiatry 2015, 15, 56. [Google Scholar] [CrossRef] [Green Version]
- Samet, J.H.; Friedmann, P.; Saitz, R. Benefits of linking primary medical care and substance abuse services: Patient, provider, and societal perspective. Arch. Intern Med. 2001, 161, 85–91. [Google Scholar] [CrossRef] [PubMed]
- Friedmann, P.D.; Zhang, Z.; Hendrickson, J.; Stein, M.D.; Gerstein, D.R. Effect of primary medical care on addiction and medical severity in substance abuse treatment program. J. Gen. Intern Med. 2003, 18, 1–8. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Cao, D.; Marsh, J.C.; Shin, H.C.; Andrews, C.M. Improving health and social outcomes with targeted services in comprehensive substance abuse treatment. Am. J. Drug Alcohol. Abuse 2011, 37, 250–258. [Google Scholar] [CrossRef]
- Umbricht-Schneiter, A.; Ginn, D.H.; Pabst, K.M.; Bigelow, G.E. Providing medical care to methadone clinic patients: Referral vs on-site care. Am. J. Public Health 1994, 84, 207–210. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Weisner, C.; Mertens, J.; Parthasarathy, S.; Moore, C. Integrating primary medical care with addiction treatment: A randomized controlled trial. JAMA 2001, 286, 1715–1723. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Dahlman, D.; Palm, Å.; Sunesdotter, C.; Troberg, K.; Wallin, C. Low-threshold primary care for patients in opiate maintenance therapy. A pilot project in Malmö, Sweden, integrates primary care and OMT. Läkartidningen 2016, 113, D33P. (In Swedish) [Google Scholar]
- Anell, A.; Glenngard, A.H.; Merkur, S. Sweden health system review. Health Syst. Transit. 2012, 14, 1–159. [Google Scholar]
- Wolf-Maier, K.; Cooper, R.S.; Banegas, J.R. Hypertension Prevalence and Blood Pressure Levels in 6 European Countries, Canada, and the United States. JAMA 2003, 289, 2363–2369. [Google Scholar] [CrossRef] [Green Version]
- SBU. Måttligt förhöjt blodtryck uppdatering 2007. En systematisk litteraturöversikt. In Stockholm Sweden: Statens beredning för medicinsk utvärdering (SBU); SBU-rapport nr 170/1U; SBU(Statens Beredning för Medicinsk Utvärdering): Stockholm, Sweden, 2007; ISBN 978-91-85413-19-5. (In Swedish) [Google Scholar]
- The Public Health Agency of Sweden (Folkhälsomyndigheten). Daily Tobacco Smoking (Daglig Tobaksrökning). 2020. Available online: https://www.folkhalsomyndigheten.se/fu-tobaksrokning-daglig/ (accessed on 26 April 2021). (In Swedish).
- Fenn, J.M.; Laurent, J.S.; Sigmon, S.C. Increases in body mass index following initiation of methadone treatment. J. Subst. Abuse Treat 2015, 51, 59–63. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Sweeney, M.M.; Antoine, D.G.; Nanda, L.; Geniaux, H.; Lofwall, M.R.; Bigelow, G.E.; Umbricht, A. Increases in body mass index and cardiovascular risk factors during methadone maintenance treatment. J. Opioid Manag. 2019, 15, 367–374. [Google Scholar] [CrossRef]
- Nolan, S.; Klimas, J.; Wood, E. Alcohol use in opioid agonist treatment. Addict. Sci. Clin. Pract. 2016, 11, 17. [Google Scholar] [CrossRef] [Green Version]
- Alammehrjerdi, Z.; Ezard, N.; Dolan, K. Methamphetamine dependence in methadone treatment services in Iran: The first literature review of a new health concern. Asian J. Psychiatr. 2018, 31, 49–55. [Google Scholar] [CrossRef]
- Ludvigsson, J.F.; Andersson, E.; Ekbom, A.; Feychting, M.; Kim, J.-L.; Reuterwall, C.; Heurgren, M.; Olausson, P.O. External review and validation of the Swedish national inpatient register. BMC Public Health 2011, 11, 450. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Spithoff, S.; Kiran, T.; Khuu, W.; Kahan, M.; Guan, Q.; Tadrous, M.; Leece, P.; Martins, D.; Gomes, T. Quality of primary care among individuals receiving treatment for opioid use disorder. Can. Fam. Physician 2019, 65, 343–351. [Google Scholar] [PubMed]
- Paquette, C.E.; Syvertsen, J.L.; Pollini, R.A. Stigma at every turn: Health services experiences among people who inject drugs. Int. J. Drug Policy 2018, 57, 104–110. [Google Scholar] [CrossRef] [PubMed]
- Bråbäck, M.; Brådvik, L.; Troberg, K.; Isendahl, P.; Nilsson, S.; Håkansson, A. Health Related Quality of Life in Individuals Transferred from a Needle Exchange Program and Starting Opioid Agonist Treatment. J. Addict. 2018, 2018, 3025683. [Google Scholar] [CrossRef] [Green Version]
- Clinical Guidelines on Drug Misuse and Dependence Update 2017 Independent Expert Working Group (2017) Drug Misuse and Dependence: UK Guidelines on Clinical Management; Department of Health: London, UK, 2017.
- Socialstyrelsen [The National Board of Health and Welfare (Socialstyrelsen). Läkemedelsassisterad Behandling vid Opioidberoende. Kunskapsstöd i Hälso- och Sjukvård och Socialtjänst. 2020. Available online: https://www.socialstyrelsen.se/globalassets/sharepoint-dokument/artikelkatalog/kunskapsstod/2020-3-6607.pdf (accessed on 26 April 2021). (In Swedish).
Characteristic | n (%) | Years (Range; Standard Deviation) |
---|---|---|
Median age | 43 (23–65; 10.1) | |
Age group | ||
23–35 years | 40 (21) | |
36–50 years | 99 (52) | |
51–65 years | 53 (28) | |
Male sex | 136 (71) | |
Country of birth | ||
Sweden | 142 (74) | |
Other country | 48 (25) | |
Missing | 2 (1) | |
Housing situation | ||
Unstable | 41 (21) | |
Stable | 148 (77) | |
Missing | 3 (2) | |
Main source of income | ||
Unstable | 113 (59) | |
Stable | 73 (38) | |
Missing | 6 (3) | |
Smoking habits | ||
Current smoker | 157 (82) | |
Not current smoker | 28 (15) | |
Missing | 7 (4) | |
Primary care record entry | 130 (68) | |
OST clinic with on-site PHC available | 81 (42) | |
Access to on-site PHC | 26 (14) |
Diagnosis | Diagnosis n (%) | Clinical Physiology Examination n (%) | Follow-Up n (%) |
---|---|---|---|
Any circulatory diagnosis | 34 (18) | 12 (6) | 12 (6) |
G45 Transient cerebral ischemic attacks and related syndromes | 1 (<1) | 1 a | 1 |
G46 Vascular syndromes of brain in cerebrovascular diseases | 0 | N/A | N/A |
I00–I02 Acute rheumatic fever | 0 | N/A | N/A |
I05–I09 Chronic rheumatic heart diseases | 1 (<1) | 1 b | 1 |
I10–I16 Hypertensive diseases | 11 (6) | 2 b | 3 |
I20–I25 Ischemic heart diseases | 2 (1) | 0 | 1 |
I26–I28 Pulmonary heart disease and diseases of pulmonary circulation | 2 (1) | 0 | 1 |
I30–I52 Other forms of heart disease | 3 (2) | 1 b | 1 |
I60–I69 Cerebrovascular diseases | 4 (2) | 1 a | 1 |
I70–I79 Diseases of arteries, arterioles and capillaries | 2 (1) | 1 b | 2 |
R00 Abnormalities of heart beat | 6 (3) | 4 c | 1 |
R01 Cardiac murmurs and other cardiac sounds | 0 | N/A | N/A |
R03 Abnormal blood-pressure reading, without diagnosis | 2 (1) | 1 d | 0 |
R09 Other symptoms and signs involving the circulatory and respiratory system | 0 | N/A | N/A |
Characteristic | PHC as Usual n (%) | On-Site PHC n (%) | OR (95% CI) | p-Value |
---|---|---|---|---|
n | 166 (100) | 26 (100) | ||
Age group a | ||||
<36 years (reference) | 33 (20) | 7 (27) | 1.00 | N/A |
36–50 years | 90 (54) | 9 (35) | 0.47 (0.16–1.37) | 0.17 |
>50 years | 43 (26) | 10 (39) | 1.10 (0.38–3.19) | 0.87 |
Male sex | 120 (72) | 16 (62) | 0.61 (0.26–1.45) | 0.27 |
Born in Sweden | 126 (76) 1 | 16 (62) | 2.07 (0.87–4.94) | 0.10 |
Unstable housing | 30 (18) 2 | 11 (42) | 3.25 (1.36–7.78) | 0.006 |
Unstable income | 98 (59) 3 | 15 (58) 4 | 1.09 (0.45–2.64) | 0.85 |
Current tobacco smoking | 135 (81) 5 | 22 (85) | 0.98 (0.31–3.09) | 0.97 |
Circulatory diagnosis b | 27 (16) | 7 (27) | 1.90 (0.73–4.95) | 0.27 |
Clinical physiology examination b | 8 (5) | 4 (15) | 3.59 (1.00–12.92) | 0.06 |
Cardiovascular follow-up b | 9 (5) | 3 (12) | 2.28 (0.57–9.03) | 0.21 |
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations. |
© 2021 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Bäckström, E.; Troberg, K.; Håkansson, A.; Dahlman, D. Healthcare Contacts Regarding Circulatory Conditions among Swedish Patients in Opioid Substitution Treatment, with and without On-Site Primary Healthcare. Int. J. Environ. Res. Public Health 2021, 18, 4614. https://doi.org/10.3390/ijerph18094614
Bäckström E, Troberg K, Håkansson A, Dahlman D. Healthcare Contacts Regarding Circulatory Conditions among Swedish Patients in Opioid Substitution Treatment, with and without On-Site Primary Healthcare. International Journal of Environmental Research and Public Health. 2021; 18(9):4614. https://doi.org/10.3390/ijerph18094614
Chicago/Turabian StyleBäckström, Eric, Katja Troberg, Anders Håkansson, and Disa Dahlman. 2021. "Healthcare Contacts Regarding Circulatory Conditions among Swedish Patients in Opioid Substitution Treatment, with and without On-Site Primary Healthcare" International Journal of Environmental Research and Public Health 18, no. 9: 4614. https://doi.org/10.3390/ijerph18094614
APA StyleBäckström, E., Troberg, K., Håkansson, A., & Dahlman, D. (2021). Healthcare Contacts Regarding Circulatory Conditions among Swedish Patients in Opioid Substitution Treatment, with and without On-Site Primary Healthcare. International Journal of Environmental Research and Public Health, 18(9), 4614. https://doi.org/10.3390/ijerph18094614